CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 14,127 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 19,847 shares at $35.05 ($695,544)
- 4 Open-market sale CEO sold 30,000 shares at $34.30 ($1,028,868)
- 4 Open-market sale Director sold 10,000 shares at $33.63 ($336,349)
- 4 Open-market sale Director sold 27,973 shares at $33.02 ($923,766)
- 4 Open-market sale CEO sold 30,000 shares at $33.98 ($1,019,430)
- 4 Open-market sale Director sold 11,905 shares at $35.00 ($416,676)
- 4 Open-market sale Director sold 4,250 shares at $35.00 ($148,750)
- 4 Open-market sale Director sold 12,250 shares at $31.74 ($388,815)
- 4 Open-market sale CEO sold 30,000 shares at $31.00 ($929,916)
- 4 Option exercise EVP AND GC acquired 8,000 shares (option exercise)
Page 20 of 35 · 686 filings